Holter ECG Market is expected to reach US$ 1,215.76 million by 2028

The global Holter ECG market is expected to reach US$ 1,215.76 million by 2028; registering at a CAGR of 8.2% from 2022 to 2028, according to a new research study conducted by The Insight partners

Product Segment Dominated Holter ECG Market in 2022

The rising incidence of cardiovascular diseases (CVDs) and growing geriatric population are the factors that contribute to the Holter ECG market growth. However, the lack of skilled professionals leading to inaccurate Holter ECG analysis is restricting the market growth.

Significant Rise in Geriatric Population

Various economies in the EU, such as the UK, Germany, France, Italy, and Spain, are witnessing considerable modernization of healthcare facilities and improvements in healthcare services. With this, the life expectancy of people has increased in these countries, leading to a growth in their geriatric population base. According to the World Economic Forum report, the proportion of people aged 65 and over has increased drastically in the past two decades. The Physical Review (PR) 2023 report states that Southern Europe, which includes countries such as Greece, Italy, Malta, Portugal, Croatia, Serbia, Slovenia, and Spain, is the oldest region in the world—accounting for 21% of the population aged over 65. Also, the Organization for Economic Cooperation and Development (OECD) reveals that the proportion of the population over 80 years in developed EU countries will double by 2050. Further, physiological aging of the heart is a major cause of CVD in aging adults due to increased oxidative stress and inflammation. Thus, the rise in the geriatric population in the EU is increasing the demand for Holter ECG monitors, thereby fueling the market growth.

Holter ECG Market, by Region, 2022 (%)

Source: The Insight Partners Analysis

Based on component, the Holter ECG market is segmented into products, software & solutions, services, and accessories. The products segment is further segmented into wired and wireless Holter monitors. In 2022, the products segment held the largest share of the market, and it is expected to register the highest CAGR during 2022–2028. The wired Holter monitors segment held the largest market share in 2022 due to growing technological improvements in Holter monitoring and rising adoption of Holter analysis software and systems (with integrated software solutions). This enables physicians or patients to upload ECG data through computers at local clinics or home computers. The same segment is expected to be dominant during the forecast period.

Many companies offering products for cardiac monitoring have their business operations in the United states and business was adversely affected by the widespread outbreak of COVID-19. This has disrupted and restricted company’s ability to distribute products, as well as temporary closures of facilities or the facilities of suppliers or customers. Moreover, market players also witnessed disruption in their business operations since March 2020, as US healthcare authorities framed policies about elective cardiac surgeries. Also, to free-up limited space for people being treated for the virus, hospitals have postponed, or cancelled. However, demand for arrhythmia monitoring devices in the region had substantial impact on the adoption of Holter ECG.

FUKUDA DENSHI; General Electric Co; EB Neuro S.P.A.; Koninklijke Philips NV; Viatom Technology Co., Ltd.; Nihon Kohden Corp; BPL Medical Technologies; OSI Systems, Inc.; Hill rom Holding Inc. (Baxter); and SCHILLER Americas Inc. are the key companies operating in the Holter ECG market.

The report segments the Holter ECG market as follows:

The Holter ECG market is segmented on the basis of component, application, end user, indication, channel, and country. Based on component, the market is segmented into products, software & solutions, services, and accessories. The products segment is further bifurcated into wired holter monitors and wireless holter monitors. Based on application, the market is bifurcated into diagnostics and monitoring. Based on indication, the market is segmented into atrial fibrillation (AF), cardiac arrest, patients with pacemakers, and others. Based on channel, the market is segmented into 3 channel ECG system; 5,6 & 7 channel ECG system; 12 channel ECG system; and others. Based on end user, the market is segmented into hospitals & clinics, home settings, ambulatory surgical centers, and others.

In terms of geography, the pulmonary arterial hypertension market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com